Hepatitis, Alcoholic Clinical Trial
Official title:
A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis
The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to placebo in AAH while studying putative mechanisms that are plausible and testable. The main hypothesis is that pentoxifylline reduces the 90-day mortality of AAH.
The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to
placebo in AAH while studying putative mechanisms that are plausible and testable. The main
hypothesis is that pentoxifylline reduces the 90-day mortality of AAH.
This study never moved forward due to funding issues.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04142723 -
Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).
|
||
| Completed |
NCT00913757 -
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
|
||
| Active, not recruiting |
NCT02404636 -
Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis
|
N/A | |
| Completed |
NCT01968382 -
Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis
|
Phase 2 | |
| Recruiting |
NCT02024295 -
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
|
Phase 4 | |
| Enrolling by invitation |
NCT04234139 -
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
|